Science Explorer Back to mapMap
Discussion
Researcher · Chinese Academy of Medical Sciences & Peking Union Medical College · China

Jie He

Jie He publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Esophageal Cancer Research and Treatment, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0002-0285-5403 OpenAlex
World rank
#109,753
of 7,710,434 ranked researchers
Rank in China
#9,683
of 978,568
Works
956
Citations
58k
Citations per work
60.8
h-index
92
i10-index 500Top 0.5% in Oncology
Jie He

What does Jie He research?

Jie He's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (3%).

Health Sciences: 386 works · 40.4% of their workMedicine: 386 works · 40.4% of their workOncology: 162 works · 16.9% of their workPulmonary and Respiratory Medicine: 142 works · 14.9% of their workSurgery: 82 works · 8.6% of their workEverything else: 337 works · 35.3% of their workLife Sciences: 232 works · 24.3% of their workBiochemistry, Genetics and Molecular Biology: 201 works · 21.0% of their workMolecular Biology: 128 works · 13.4% of their workCancer Research: 73 works · 7.6% of their workImmunology and Microbiology: 32 works · 3.3% of their workImmunology: 32 works · 3.3% of their workTHEIR WORKJie He956works
Life Sciences24%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine38640.4%
  2. Everything else33735.3%
    1. Biochemistry, Genetics and Molecular Biology20121.0%
    2. Immunology and Microbiology323.3%
  1. 1Oncology17% of their works
  2. 2Pulmonary and Respiratory Medicine15% of their works
  3. 3Molecular Biology13% of their works
  4. 4Surgery9% of their works
  5. 5Cancer Research8% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Jie He's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Esophageal Carcinoma, Preoperative Chemoradiotherapy, ALK Inhibitors, EGFR Mutations and CT Screening.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Clinical Trials1622 topics
  2. Targeted Therapy1622 topics
  3. Chemotherapy1592 topics
  4. Esophageal Carcinoma1141 topic
  5. Preoperative Chemoradiotherapy1141 topic
  6. ALK Inhibitors1051 topic
  7. EGFR Mutations1051 topic
  8. CT Screening1021 topic
  9. Lung Cancer1021 topic
  10. Immune Checkpoint Blockade991 topic
  11. PD-1 and PD-L1991 topic
  12. RNA methylation661 topic
  13. m6A-seq661 topic
  14. Aquaculture641 topic
  15. Nutrition641 topic
  16. Cancer Incidence631 topic
  17. Mortality Rates631 topic
  18. Genomic Profiles571 topic
  19. Small-Cell Lung Cancer571 topic

Where does Jie He work?

Jie He's main affiliation in the publication record is Chinese Academy of Medical Sciences & Peking Union Medical College, China.

How many publications and citations does Jie He have?

OpenAlex counts 956 works and 58,135 citations for Jie He, an h-index of 92, ranking #109,753 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jie He

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jie He. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.